Ankylosing spondylitis - Centre for Musculoskeletal Health and Work
Learn about our centre based at the University of Southampton - a world-leading centre focused on reducing the impact of MSK disorders in the workplace.
Live research projects
Ankylosing spondylitis - Do anti-inflammatory drugs undermine the use of MRI as a means of assessing inflammation in axial spondyloarthritis?
Learn more about do anti-inflammatory drugs undermine the use of MRI as a means of assessing inflammation in axial spondyloarthritis?
Ankylosing spondylitis - How can we effectively manage patients who have axial spondyloarthritis and fibromyalgia?
Learn more about the how can we effectively manage patients who have axial spondyloarthritis and fibromyalgia.
Ankylosing spondylitis - How does the RUNX3 gene increase the likelihood of developing ankylosing spondylitis?
Learn about our research into whether the RUNX3 gene, which is important for immune cells, can be targeted for the development of new and effective treatments.
Ankylosing spondylitis - Lessening the impact of fatigue: Therapies for Inflammatory Rheumatic Diseases (LIFT)
Learn about our research into access to treatments, such as physical activity and talking therapy, to alleviate fatigue from inflammatory rheumatic conditions.
Ankylosing spondylitis - Preventing unwanted bone formation in arthritis
Learn about our study of molecules produced by cells of the immune system and their role in new bone formation in osteoarthritis and ankylosing spondylitis.
Ankylosing Spondylitis - Targeting messengers in the immune system
Read more about our research into messengers in the immune system (GM-CSF), their role in causing ankylosing spondylitis and whether they can be targeted.
Ankylosing spondylitis - Understanding genetic risk of ankylosing spondylitis
Learn about our research into identifying the gene function alterations involved in the inflammation and new bone formation seen in ankylosing spondylitis.
Ankylosing spondylitis - Understanding the role of gut bacteria to develop new treatments for inflammatory arthritis
Learn more about our research into gut bacteria and their role in the development of inflammatory arthritis and in determining your response to treatment.
Ankylosing spondylitis - Understanding the role of T cells in ankylosing spondylitis
Read about our research into understanding how T cells are involved in causing disease and identifying potential new treatments to target the T-cells.
Ankylosing spondylitis - Understanding the role of the NOS2 gene in ankylosing spondylitis
Read about our research, which aims to build upon evidence that the NOS2 gene plays a role in ankylosing spondylitis to help to develop new treatments.
Ankylosing spondylitis - Using zebrafish to understand how and why osteoarthritis develops
Read how our research group have pioneered the use of zebrafish, which have similar genes to humans, for research into osteoarthritis and related conditions.
Antiphospholipid syndrome - Rivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE (RISAPS)
Learn more about if a new blood thinning drug improve treatment for patients with lupus or thrombotic antiphospholipid syndrome at risk of stroke.
AS | The link between blood vessels and bone damage
Learn about our research and study of two genes - aiming to improve our understanding of the processes involved in controlling inflammation and bone damage.
Axial spondyloarthritis - How replacing gut bacteria could treat people with axial spondyloarthritis
Read about our research on how replacing gut bacteria could treat people with axial spondyloarthritis.